Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Suspended1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT04909047Not ApplicableRecruiting

The Effectiveness of Parassacral Transcutaneous Stimulation Compared to Tibial Transcutaneous Stimulation, Home Protocol and Behavioral Therapy in the Treatment of Female Hyperative Bladder: Randomized Clinical Trial

NCT04408352Not ApplicableSuspendedPrimary

RF Ablation of the Trigone for the Treatment of UUI

Showing all 2 trials

Research Network

Activity Timeline